Concepedia

Author

Edward Pequignot

Thomas Jefferson University

Also Known As

E PEQUIGNOT, E Pequignot, E. Pequignot, E.C. Pequignot, Edward C. PEQUIGNOT, Edward C. Pequignot, Edward Pequignot

84

Publications

6.5K

Citations

26

H-Index

77

Concepts

All Affiliations

Thomas Jefferson UniversityUniversity of PennsylvaniaParker Institute for Cancer ImmunotherapyNovartis (United States)Sidney Kimmel Cancer Center
EP

About

Edward Pequignot is an author at Thomas Jefferson University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

3.3K

2

Health Sciences

4

4

508

3

Education

1

1

132

4

Natural Sciences

1

1

55

5

Public Health

1

1

95

Edward Pequignot

×

38

Publications

6.4K

Citations

26

H-Index

YearCitations

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando,

Nature Medicine

2018

1.7K

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

David T. Teachey, Simon F. Lacey, Pamela A. Shaw,

Cancer Discovery

2016

1.1K

Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice

Xiaojun Liu, Shuguang Jiang, Chongyun Fang,

Cancer Research

2015

554

A randomized, controlled trial of mindfulness‐based art therapy (MBAT) for women with cancer

Daniel Monti, Caroline Peterson, E Kunkel,

Psycho-Oncology

2005

357

Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas

Shannon Fogh, David W. Andrews, Jon Glass,

Journal of Clinical Oncology

2010

342

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia

Noelle V. Frey, Pamela A. Shaw, Elizabeth O. Hexner,

Journal of Clinical Oncology

2019

259

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy

David T. Teachey, Edward Pequignot, Noelle V. Frey,

Journal of Immunological Methods

2016

190

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia

Noelle V. Frey, Saar Gill, Elizabeth O. Hexner,

Journal of Clinical Oncology

2020

181

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Allison Barz Leahy,

Journal of Clinical Oncology

2021

177

Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy

Maria Werner‐Wasik, Edward Pequignot, Dennis B. Leeper,

International Journal of Radiation Oncology*Biology*Physics

2000

138

Page 1